Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price fell 5% on Monday . The stock traded as low as GBX 1.49 and last traded at GBX 1.52. Approximately 552,378 shares changed hands during trading, a decline of 71% from the average daily volume of 1,893,829 shares. The stock had previously closed at GBX 1.60.
Cizzle Biotechnology Stock Performance
The stock’s 50 day simple moving average is GBX 1.77 and its 200-day simple moving average is GBX 2.22. The firm has a market cap of £6.80 million, a price-to-earnings ratio of -9.41 and a beta of 0.02.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
- Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
- Micron’s AI Memory Boom Could Send Shares 100% Higher
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
